RESEARCHER PROFILE

Pablo Mir

← Back to Universidad de Sevilla

P

Universidad de Sevilla

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and EpidemiologyObsessive-Compulsive Spectrum Disorders

Pablo Mir works in Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Dementia and Cognitive Impairment Research, Genetic Associations and Epidemiology, Obsessive-Compulsive Spectrum Disorders. Recorded institutional associations include Consejo Superior de Investigaciones Científicas, Instituto de Salud Carlos III, Biomedical Research Networking Center on Neurodegenerative Diseases.

381Publications
16,727Citations
59H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. New insights into the genetic etiology of Alzheimer’s disease and related dementias

    2022 · 2,462 citations
  2. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    2019 · 2,427 citations
  3. Analysis of shared heritability in common disorders of the brain

    2018 · 1,915 citations
  4. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    2019 · 1,373 citations
  5. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

    2021 · 322 citations
  6. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

    2017 · 309 citations
  7. International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease

    2009 · 262 citations
  8. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study

    2010 · 248 citations
  9. Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)

    2007 · 247 citations
  10. Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

    2008 · 234 citations
  11. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease

    2009 · 213 citations
  12. Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum

    2008 · 209 citations
  13. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    2021 · 208 citations
  14. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease

    2017 · 207 citations
  15. Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets

    2021 · 198 citations
  16. European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

    2022 · 190 citations
  17. De Novo Coding Variants Are Strongly Associated with Tourette Disorder

    2017 · 187 citations
  18. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients

    2009 · 175 citations
  19. Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    2019 · 163 citations
  20. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers

    2006 · 146 citations
  21. Effects of Two Weeks of Cerebellar Theta Burst Stimulation in Cervical Dystonia Patients

    2014 · 146 citations
  22. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

    2021 · 145 citations
  23. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

    2019 · 144 citations
  24. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

    2019 · 143 citations
  25. Tremor stability index: a new tool for differential diagnosis in tremor syndromes

    2017 · 140 citations

← Return to the university profile